Researchers reveal mechanisms of how CDK12 alterations drive prostate cancer development

When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew they needed to understand how this genetic alteration was driving cancer and how to target it with treatment.

Shrinking COVID vaccine sales has Moderna course-correcting

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. There’s potential that a

November 3, 2023

CMR Surgical gets FDA de novo nod for Versius robot

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: CMR Surgical won Food and

October 17, 2024

New tool predicts nerve damage risk from breast cancer treatment

Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system.

July 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.